Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Capital Leases: 2009-2015

Historic Capital Leases for Madrigal Pharmaceuticals (MDGL) over the last 6 years, with Sep 2015 value amounting to $11,000.

  • Madrigal Pharmaceuticals' Capital Leases fell 79.63% to $11,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $11,000, marking a year-over-year decrease of 79.63%. This contributed to the annual value of $43,000 for FY2014, which is 49.41% down from last year.
  • Madrigal Pharmaceuticals' Capital Leases amounted to $11,000 in Q3 2015, which was down 50.00% from $22,000 recorded in Q2 2015.
  • Madrigal Pharmaceuticals' 5-year Capital Leases high stood at $117,000 for Q1 2011, and its period low was $1,000 during Q4 2012.
  • Over the past 3 years, Madrigal Pharmaceuticals' median Capital Leases value was $48,500 (recorded in 2014), while the average stood at $48,500.
  • Per our database at Business Quant, Madrigal Pharmaceuticals' Capital Leases plummeted by 98.14% in 2011 and then spiked by 8,400.00% in 2013.
  • Madrigal Pharmaceuticals' Capital Leases (Quarterly) stood at $14,000 in 2011, then crashed by 92.86% to $1,000 in 2012, then soared by 8,400.00% to $85,000 in 2013, then crashed by 49.41% to $43,000 in 2014, then tumbled by 79.63% to $11,000 in 2015.
  • Its Capital Leases was $11,000 in Q3 2015, compared to $22,000 in Q2 2015 and $33,000 in Q1 2015.